It’s hard to believe that we are already a full quarter into 2022 – and a busy one it’s been -particularly for the regulatory landscape. AARDEX® Group also announced the first in a series of virtual events, a live panel debate … Read More
Author Archives: Bernard Vrijens
Industry Stakeholders Respond to FDA’s Draft Digital Health Technology Guidance
In December last year, the Food and Drug Administration (FDA) issued new draft guidance (Digital Health Technologies for Remote Data Acquisition in Clinical investigations) on what kinds of devices and software may be used for remote monitoring of clinical trial … Read More
Innovative Health Initiative Pledges to Help Break Silos Between Basic Research, Medical Disciplines, and Technological Areas.
Technology presents the healthcare community with a golden opportunity to improve lives – but only if we embrace that potential. Success, according to the Innovative Health Initiative’s Strategic Research and Innovation Agenda, depends on cross-sector collaboration. Across Europe, healthcare faces … Read More
FDA Issues Proposed Guidance for the use of Digital Health Technology in Clinical Investigations
In recent years, a multitude of Digital Health Technologies (DHTs) have emerged, many with the ability to solve some of the biggest problems in clinical trials. However, uptake has been slow. Now, proposed new Food and Drug Administration (FDA) guidelines … Read More
Paving the Way for Optimal Patient Adherence in Clinical Research
For far too long, poor patient adherence has been the elephant in the room. The common, age-old problem has the potential to bring a clinical trial to its knees, and yet with no workable solution on the table, sponsors and CROs have … Read More
The Case for Measuring and Managing Patient Adherence
According to the World Health Organization, up to half of the patients with chronic diseases fail to take their medications properly.1 Research shows many patients who are part of clinical trials do not maintain medication adherence either.2 Among many things, poor patient adherence … Read More
Removing the Barriers that Hinder Patient Adherence
Poor patient adherence tends to be a matter of people not taking their medicine as prescribed, due to access barriers. So how can placing an additional burden on patients be the answer? As an industry, we are more than aware … Read More
AARDEX Group Joins Innovative IT4Anxiety Project
Innovative medication adherence tools in a real-world hospital setting to reduce anxiety in users of mental health services. Liege, Belgium – March 3, 2022: Belgium-based AARDEX Group, the global leader in Digital Tools for measuring and managing adherence to medication, today announced they have … Read More
EU Clinical Trials Regulation Creates a Framework for the Future of Research
Recent advances in medical science are providing new hope for people living with unmet needs – but modern medicines are only one side of the coin. Ensuring new treatments move from bench side to bedside as soon as possible is … Read More
Smart Packaging in Clinical Trials: The Missing Piece in the Medication Adherence Puzzle
Poor adherence to medication has been costing lives and money for decades – but cutting-edge solutions are now on hand to solve the age-old problem. It is no secret that the medical community has a problem with patient compliance: patients … Read More